The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Restless Legs SyndromeModerate to Severe Idiopathic Restless Legs Syndrome (RLS)
Interventions
DRUG

Ropinirole

Trial Locations (50)

10117

GSK Investigational Site, Berlin

10625

GSK Investigational Site, Berlin

10629

GSK Investigational Site, Berlin

10787

GSK Investigational Site, Berlin

10969

GSK Investigational Site, Berlin

12167

GSK Investigational Site, Berlin

13053

GSK Investigational Site, Berlin

13156

GSK Investigational Site, Berlin

15526

GSK Investigational Site, Bad Saarow

17389

GSK Investigational Site, Anklam

19053

GSK Investigational Site, Schwerin

23966

GSK Investigational Site, Wismar

26122

GSK Investigational Site, Oldenburg in Holstein

28832

GSK Investigational Site, Achim

31134

GSK Investigational Site, Hildesheim

33330

GSK Investigational Site, Gütersloh

33647

GSK Investigational Site, Bielefeld

34128

GSK Investigational Site, Kassel

35510

GSK Investigational Site, Butzbach

35745

GSK Investigational Site, Herborn

37073

GSK Investigational Site, Göttingen

37075

GSK Investigational Site, Göttingen

38440

GSK Investigational Site, Wolfsburg

40212

GSK Investigational Site, Düsseldorf

44787

GSK Investigational Site, Bochum

44791

GSK Investigational Site, Bochum

44805

GSK Investigational Site, Bochum

44809

GSK Investigational Site, Bochum

44892

GSK Investigational Site, Bochum

45525

GSK Investigational Site, Hattingen

45879

GSK Investigational Site, Gelsenkirchen

52349

GSK Investigational Site, Düren

52428

GSK Investigational Site, Jülich

61348

GSK Investigational Site, Bad Homburg

67117

GSK Investigational Site, Limburgerhof

73479

GSK Investigational Site, Ellwangen

73760

GSK Investigational Site, Ostfildern

79104

GSK Investigational Site, Freiburg im Breisgau

80331

GSK Investigational Site, Munich

82008

GSK Investigational Site, Unterhaching

89073

GSK Investigational Site, Ulm

89081

GSK Investigational Site, Ulm

90403

GSK Investigational Site, Nuremberg

93053

GSK Investigational Site, Regensburg

97070

GSK Investigational Site, Würzburg

01307

GSK Investigational Site, Dresden

06118

GSK Investigational Site, Halle

06366

GSK Investigational Site, Köthen

07551

GSK Investigational Site, Gera

07743

GSK Investigational Site, Jena

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00357097 - The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome | Biotech Hunter | Biotech Hunter